Advertisement

Topics

Latest "DeCODE Genetics ARUP Laboratories" News Stories

04:28 EDT 22nd July 2018 | BioPortfolio

Here are the most relevant search results for "DeCODE Genetics ARUP Laboratories" found in our extensive news archives from over 250 global news sources.

More Information about DeCODE Genetics ARUP Laboratories on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about DeCODE Genetics ARUP Laboratories for you to read. Along with our medical data and news we also list DeCODE Genetics ARUP Laboratories Clinical Trials, which are updated daily. BioPortfolio also has a large database of DeCODE Genetics ARUP Laboratories Companies for you to search.

Showing "DeCODE Genetics ARUP Laboratories" News Articles 1–25 of 3,300+

Extremely Relevant

deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15022018] Prices from USD $350

deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's deCODE genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by de...


Relevant

ARUP Laboratories Strategic SWOT Analysis Review [Report Updated: 21022018] Prices from USD $125

ARUP Laboratories Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business b...

Iceland’s Ethical Debate: Should DNA Donors Be Told if They Are Predisposed to a Deadly Disease?

(Canadian Broadcast Co) – If you knew someone was genetically predisposed to cancer, would you tell them? Dr. Kari Stefansson would. The Icelandic neurologist is the CEO of deCODE Genetics, a company that has collected the DNA of nearly half … Read More


R&D Head Sean Harper On Amgen's Long-Term Investment View

Amgen is validating targets through the deCODE Genetics investment it made five years and moving drugs into the clinic. It's...   

ARUP Laboratories Medical Equipment Deals and Alliances Profile [Report Updated: 13022018] Prices from USD $250

SummaryARUP Laboratories ARUP is a clinical and anatomical pathology reference laboratory. It is a nonprofit enterprise of the University of Utah and its Department of Pathology. The company provides several tests and test combinations in the fields of anatomic pathology, genetics, pain management, general oncology, hematologic oncology, hemostasis/thrombosis, immunohematology, molecular infectiou...

John E. Sulston, Nobel-winning scientist who helped decode human genome, dies at 75 – Washington Post

Washington PostJohn E. Sulston, Nobel-winning scientist who helped decode human genome, dies at 75Washington PostJohn E. Sulston, a scientist who won the Nobel Prize for work on one of the lowliest of nature's creatures, which provided insights into the genetic processes by which human beings develop, and who also led the British effort to decode the human genome ...Sir John Sulston and the Human ...

Reviewing IDEXX Laboratories (IDXX) & The Competition

IDEXX Laboratories is one of 25 publicly-traded companies in the "Diagnostic substances" industry, but how does it contrast to its rivals? We will compare IDEXX Laboratories to related businesses based on the strength of its dividends, analyst recommendations, institutional ownership, earnings, profitability, valuation and risk. IDEXX Laboratories has higher revenue and earnings than its rivals.

Myriad Reports Approval For BRACAnalysis Diagnostic System In Japan

LONDON (dpa-AFX) - Myriad Genetic Laboratories, Inc., a subsidiary of Myriad Genetics, Inc. (MYGN), announced the Japanese Ministry of Health, Labour, and Welfare has granted manufacturing and mar...

PharmaMar lizensiert vollsynthetisch aus Meeressubstanzen gewonnene Payloads für Wirkstoff-Konjugate an Seattle Genetics

Madrid (ots/PRNewswire) - PharmaMar (MCE: PHM) hat heute die Unterzeichnung einer exklusiven Lizenzvereinbarung mit Seattle Genetics Inc. (SGEN: NASDAQ GS) bekanntgegeben, nach der Seattle Genetics...

Quotidian Technical Highlights on Selected Healthcare Stocks -- Atossa Genetics, Palatin ...

www.wallstequities.com/registration Atossa Genetics On Thursday, shares in Seattle, Washingtonheadquartered Atossa Genetics Inc. recorded a trading volume of 2.03 million shares. The stock ended at Read more...

Reviewing Impax Laboratories

Impax Laboratories and Corcept Therapeutics are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. 90.5% of Impax Laboratories shares are owned by institutional investors.

ASHG honors Jan M. Friedman with Arno Motulsky-Barton Childs Award

(American Society of Human Genetics) The American Society of Human Genetics (ASHG) has named Jan M. Friedman, M.D., Ph.D., as the 2018 recipient of the Arno Motulsky-Barton Childs Award for Excellence in Human Genetics Education. Dr. Friedman is a Professor of Medical Genetics at the University of British Columbia (UBC). This award recognizes an individual for contributions of exceptional quality ...

Seattle Genetics To Acquire Cascadian Therapeutics

NewsThe acquisition will enhance Seattle Genetics’ portfolio of solid tumor programs with potential rapid registration pathways and provides global rights to a pivotal Phase 2 program in development for HER2-positive metastatic breast cancer therapy.

What a Dog Geneticist Wants You to Know about Dog Genetics

What dog lovers get right, and wrong, about dog genetics -- Read more on ScientificAmerican.com

Unum gets $5mm investment from Seattle Genetics

Concurrent with closing its initial public offering, Unum Therapeutics Inc. sold partner Seattle Genetics Inc. 416,666 common...

CSI Laboratories Announces Construction of New Cancer Diagnostics Laboratory in Florida

CSI Laboratories, a national cancer diagnostics laboratory based in Atlanta, Georgia, is expanding its operations to Jupiter, Florida, to better serve pathology and oncology communities throughout the state. Rapid specialty diagnostics are crucial for cancer patients who must often wait days or sometimes weeks before they know their diagnosis or can begin...

Critical Comparison: Impax Laboratories

Impax Laboratories and Innocoll are both small-cap pharmaceuticals - nec companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations. Innocoll has lower revenue, but higher earnings than Impax Laboratories.

Advance genetics study identifies virulent strain of TB

(Liverpool School of Tropical Medicine) LSTM's Dr Maxine Caws is co-lead investigator on an advanced genetics study published in Nature Genetics(link is external), which has shown that a virulent strain of tuberculosis (TB) has adapted to transmit among young adults in Ho Chi Minh City, Vietnam.

Esoteric Testing Market by Type Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing, Lab Type Independent Labs, Hospital Laboratories, Technology Mass Spectrometry, CLIA, ELISA, PCR Global Forecast to 2023 [Rep

Esoteric testing market projected to grow at a CAGR of 11.6%The esoteric testing market is projected to reach USD 35.24 billion by 2023 from USD 20.38 billion in 2018, at a CAGR of 11.6%. Growth in this market is primarily driven by the increasing burden of chronic diseases majorly due to the rising geriatric population, rising prevalence of infectious diseases, rising demand for early disease dia...

Seattle Genetics to Acquire Cascadian Therapeutics for $614 Million, Adding Late-Stage Breast Cancer Program

att BOTHELL, Wash. & SEATTLE–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) and Cascadian Therapeutics, Inc. (Nasdaq:CASC) today announced the signing of a definitive merger agreement under which Seattle Genetics has agreed to acquire Cascadian Therapeutics. Under the terms of the agreement, Seattle Genetics will pay $10.00 per share in cash, or approximately $614 million. T...

Seattle Genetics Looking To Improve, Replace Standards Of Care

Seattle Genetics is transitioning from a one-product to multi-product company while growing its established Adcetris franchise. New studies are coming...    

‘Bill Of The Month’: A College Student’s $17,850 Drug Test

Kaiser Health News, in collaboration with NPR, kicks off a series that will examine and decode your perplexing medical bills.

Leading genetics study method may need reconsideration, significant distortions discovered

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Many conclusions drawn from a common approach to the study of human genetics could be distorted because of a previously overlooked phenomenon, according to researchers at the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai and collaborators from Massachusetts General Hospital and the Broad Insti...

ASHG honors Andrew Adey with early-career award

(American Society of Human Genetics) The American Society of Human Genetics (ASHG) has named Andrew Adey, Ph.D., as the recipient of the 2018 Early-Career Award. Dr. Adey is an Assistant Professor for the Department of Molecular & Medical Genetics within the School of Medicine at Oregon Health & Science University (OHSU). This award recognizes the contributions of genetics and genomics scientists ...

Asuragen to Present at 2018 ACMG Annual Clinical Genetics Meeting

Presentations on upcoming expansion of genetics products portfolio Asuragen, Inc., a molecular diagnostics company delivering easy to use products for complex testing in genetics and oncology, will highlight several of its new products launching this year at the upcoming ACMG Annual Clinical Genetics Meeting on April 10-14 in Charlotte, North Carolina....


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks